RHO and cancer: We also found that the Rho/ROCK/MLC2 signaling pathway, which can be targeted by the ROCK inhibitor Y-27632, was involved in the increase in cell motility in A549 cells after C-ion irradiation, suggesting that ROCK inhibition may reduce the migration of the irradiated cancer cells when used in combination with C-ion RT.